Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1080/14737140.2016.1226136
Reference118 articles.
1. Global cancer statistics, 2012
2. An Analysis of 412 Cases of Hepatocellular Carcinoma at a Western Center
3. Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma
4. Continuous Improvement of Survival Outcomes of Resection of Hepatocellular Carcinoma
5. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma;Cancers;2023-09-07
2. Efficacy and prognostic factors of repeated hepatectomy for postoperative intrahepatic recurrence of hepatocellular carcinoma undergoing initial hepatectomy;Frontiers in Medicine;2023-05-11
3. Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges;World Journal of Gastrointestinal Surgery;2023-04-27
4. Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study;Cancer Medicine;2023-03-31
5. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2023-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3